By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nymox Pharmaceutical Corporation 

175 Bouchard, Suite 100

Dorval  Quebec  H9S 1B1  Canada
Phone: 514-636-3122 Fax:


SEARCH JOBS








Company News
Nymox Pharmaceutical (NYMX) Announces Positive Prostate Cancer 8 Month Clinical Trial Results 9/10/2014 8:13:22 AM
Nymox Pharmaceutical (NYMX) Reports Second Quarter 2014 Financial Results 8/11/2014 7:52:01 AM
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014 7:35:45 AM
Nymox Pharmaceutical (NYMX) Announces Completion Of Enrollment For Second BPH Re-Injection Study 7/15/2014 9:16:16 AM
Nymox Pharmaceutical (NYMX) Reports Positive Update On Nerve Sparing And Sexual Function Preservation In Men Treated With NX-1207 6/17/2014 9:06:23 AM
Nymox Pharmaceutical (NYMX) Reports Positive New Safety Study Data For Phase 3 BPH Drug 6/12/2014 7:21:35 AM
Nymox Pharmaceutical (NYMX) Reports New Results On Favorable Side Effect Profile Of NX-1207 Treatment 5/21/2014 9:13:54 AM
Nymox Pharmaceutical (NYMX) Reports First Quarter 2014 Financial Results 5/15/2014 11:50:38 AM
Nymox Pharmaceutical (NYMX) Reports Positive Results Showing That NX-1207 Treatment For Prostate Cancer Does Not Affect Testosterone Levels 5/13/2014 11:37:32 AM
Nymox Pharmaceutical (NYMX) Announces Completion Of Second Pivotal Phase 3 NX-1207 Trial For BPH 5/8/2014 9:11:35 AM
12345678910...
//-->